Your browser doesn't support javascript.
loading
Changes in survival in de novo metastatic cancer in an era of new medicines.
Luyendijk, Marianne; Visser, Otto; Blommestein, Hedwig M; de Hingh, Ignace H J T; Hoebers, Frank J P; Jager, Agnes; Sonke, Gabe S; de Vries, Elisabeth G E; Uyl-de Groot, Carin A; Siesling, Sabine.
Affiliation
  • Luyendijk M; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
  • Visser O; Erasmus School of Health Policy & Management, Erasmus University, Rotterdam, the Netherlands.
  • Blommestein HM; Department of Registration, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
  • de Hingh IHJT; Erasmus School of Health Policy & Management, Erasmus University, Rotterdam, the Netherlands.
  • Hoebers FJP; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
  • Jager A; Department of Radiation Oncology (MAASTRO), Research Institute GROW, Maastricht University, Maastricht, the Netherlands.
  • Sonke GS; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • de Vries EGE; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Uyl-de Groot CA; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Siesling S; Erasmus School of Health Policy & Management, Erasmus University, Rotterdam, the Netherlands.
J Natl Cancer Inst ; 115(6): 628-635, 2023 06 08.
Article in En | MEDLINE | ID: mdl-36978244

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms / Neoplasms, Second Primary / Neuroendocrine Tumors Type of study: Observational_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms / Neoplasms, Second Primary / Neuroendocrine Tumors Type of study: Observational_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Países Bajos